Telesair is a high-growth company that is developing breakthrough solutions to help move patients from hospital to home sooner by providing compact, mobile respiratory care solutions to hospitals, long-term care and skilled nursing facilities, rural health providers, and in the homecare setting. Led by respiratory veterans in both R&D and commercialization, the company has developed a next-gen, advanced respiratory treatment system platform based on state-of-the-art sensor fusion technologies and innovative pneumatics. Telesair's solutions are designed to elevate the existing standard of care by improving outcomes for patients and the health system.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/10/23 | $22,000,000 | Series A |
Berkeley Catalyst Fund Device of Tomorrow Capital Pasaca Capital  ShangBay Capital Ultrastar Ventures ZhenCheng Capital | undisclosed |
